Collaborative Study Proposal: Renal Cell Cancer in Lynch Syndrome.

Slides:

Advertisements

Similar presentations

Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.

Advertisements

Suggestions for PMS2 best practice Jenny Simmonds

Regional Perspectives on Renal Cell Carcinoma Mohamed Abdulla M.D. Professor of Clinical Oncology Cairo University AfME. September 17 th 2010W:

NEW APPROACHES IN CANCER PATHOLOGY - LESSONS FROM RENAL CARCINOMA STEWART FLEMING UNIVERSITY OF DUNDEE.

Universal Screening of Lynch Syndrome Heather Hampel, MS, CGC Clinical Associate Professor, Division of Human Genetics.

Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,

COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.

Renal Tumours n Mr C Dawson MS FRCS n Consultant Urologist n Fitzwilliam Hospital n Peterborough.

Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.

Mechanisms and Epidemiology of Colon Cancer

About these slides SPEC – Short Presentation in Emerging Concepts

Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.

Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.

Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.

HENRY T. LYNCH, MD JANE F. LYNCH, BSN Creighton University

1 PRACTICAL ASPECTS OF ASSESSING MSI STATUS: WHAT TESTS TO ORDER AND HOW TO INTERPRET THEM by HENRY T. LYNCH, M.D. JANE F. LYNCH, B.S.N. CARRIE SNYDER,

1 HEREDITARY COLON CANCER: LYNCH SYNDROME – PAST, PRESENT AND THE FUTURE HENRY T. LYNCH, MD JANE F. LYNCH, BSN Creighton University School of Medicine.

Management of T1 Kidney Cancer Laparoscopic Surgery

Evaluating cell lines as tumor models by comparison of genomic profiles Domcke, S. et al. Nat. Commun 4:2126.

Genetic and Molecular Epidemiology

Immunohistochemistry (IHC) for Microsatellite Instability Fact Sheet Frequently Asked Questions What is Lynch Syndrome? Lynch syndrome is a hereditary.

Genetics & Colorectal Cancer

Genetics and Ovarian Cancer June 16, 2015 Ovarian Cancer Alliance of Oregon and SW Washington Becky Clark, MS, CGC Genetic Counselor.

Taiwan 2000 PETACC 3 ASCO 2009 Molecular markers in colon cancer have a stage specific prognostic value. Results of the translational study on the PETACC.

Ademola Popoola,BUHARI TAJUDEEN,Fidelis Ushie,Hamid Olanipekun. Department of Surgery University of Ilorin Teaching Hospital,Ilorin. Multiple Primary Cancers.

1 MICROSATILLITE INSTABILITY IN CRC HENRY T. LYNCH, MD JANE F. LYNCH, BSN Creighton University School of Medicine Omaha, Nebraska.

LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:

Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.

RPS ZU. Mrs. Liliane D…., 72 year-old No past medical history Mai 2011 – Loss of weight (4kg in 6 months) – Asthenia Thoraco-abdomino pelvic.

סרטן מעי גס אבחון מוקדם מניעה טיפול מונע ד"ר הוברט אילה מנהלת המרכז לגידולים במערכת העיכול מכון שרת הדסה עין כרם.

COMPLETE LOSS OF SUCCINATE DEHYDROGENASE B (SDHB) IN PEDIATRIC GASTROINTESTINAL STROMAL TUMORS (GIST) Katherine A. Janeway, MD November 7, 2009 Connective.

Uterine Cancer Endometrial (or uterine) cancer will account for 50,000 new cases and 8200 deaths in the United States in Two genetic disorders are.

MSH2 and Hereditary Nonpolyposis Colorectal Cancer By Bobby Glenn Warren III.

Genetic predisposition to

1 LYNCH SYNDROME EPCAM FAMILY WITH PREDOMINANT COLORECTAL CANCER HENRY T. LYNCH, MD; STEPHEN N. THIBODEAU, PHD; CARRIE SNYDER, MSN, RN, APNG; JENNIFER.

Kidney Cancer Like other cancers, kidney or “renal cell” cancer has a family history in 4% of the cases. Familial kidney cancers, like sporadic cases,

MLH1: Hereditary nonpolyposis colon cancer (HNPCC) By: Alison Edge.

Clinicopathologic Features of EML4-ALK Mutant Lung Cancer Shaw AT et al. ASCO 2009; Abstract (Poster)

Malignant Renal tumors DR.Gehan Mohamed. Malignant renal tumors - It may be: - primary tumors : i.e arise from kidney tissue itself - Secondary tumors:

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer In association.

Clear cell carcinoma of the ovary

High frequency of early colorectal cancer in inflammatory bowel disease M W M D Lutgens, F P Vleggaar, M E I Schipper, P C F Stokkers, C J van der Woude,

Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,

TPMI Research Day October 8th, 2015

A Retrospective Analysis of Microsatellite Instability testing on colorectal cancer specimens in Queensland Public Hospitals Matthew Burge; Hayden Christie;

Gender difference in age, risk factors and histological characteristics of lung cancer patients, presented to the Respiratory Unit of Teaching Hospital.

Hereditary Gastrointestinal Cancers

UROGENITAL SYSTEM LAB -1

Development of preclinical models for the guidance of precision medicine. Development of preclinical models for the guidance of precision medicine. A,

KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers Katharina Balschun, Jochen Haag, Ann-Kathrin.

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

Representative 3-generation pedigrees for serous cancer probands suggestive of inherited cancer susceptibility. Representative 3-generation pedigrees for.

Ajay Goel, Takeshi Nagasaka, Jennifer Spiegel, Richard Meyer, Warren E

Geoffrey R. Oxnard, MD, Vincent A. Miller, MD, Mark E

Noralane M Lindor Clinical Gastroenterology and Hepatology

DiagMMR™ assay validation sample collection

Short Presentations in Emerging Concepts (SPEC)

Published online September 20, 2017 by JAMA Surgery

Sergio Bracarda European Urology Supplements

CT Characteristics and Pathologic Basis of Solitary Cystic Lung Cancer

NAACCR/IACR Combined Annual Conference 2019

A, SSA/P is seen in the right colon (outlined by arrows) at colonoscopy. A, SSA/P is seen in the right colon (outlined by arrows) at colonoscopy. Note.

A, Proportion of variants detected in the MMR genes.

Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

Molecular definitions of lung adenocarcinoma subtypes.

Reduced expression of the tumor suppressor PTEN occurs in tumors with both squamous cell and adenocarcinoma histology. Reduced expression of the tumor.

Genetic analysis suggests the presence of four clinically relevant groups of histologically defined anaplastic oligodendrogliomas. Genetic analysis suggests.

CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.

Presentation transcript:

Collaborative Study Proposal: Renal Cell Cancer in Lynch Syndrome

Background Several reports of synchronous or metachronous RCC and CRC Not statistically significant for RCCs overall Significant association with papillary RCC 1 Familial association in population based study 2 Increased risk in 2 registry- based series – SIR 4.7 (1-14) 1 – SIR ( ) (2 RCC + 1 R pelvis) 2 Mean age at dx: 74 (47-88) yrs Histology: – 4 “adenocarcinoma” 3 – 1 tubulopapillary 4 MSI: 1/5 MSI-H 4,5 IHC: loss in 3 5, no loss in Thompson et al. 2006; 2 Hemminki and Chen Aarnio et al. 1999; 2 Win et al. 2012; 3 Aarnio et al. 2012; 4 Mongiat-Artus et al. 2006; 5 Gylling et al RCC AND CRCRCC IN LS

Renal cell carcinomas in Florence LS patients PT (SEX) MUTATIONCANCERS (YRS AT DX) RCC HISTOLOGY MSI STATUSIHC 4 (M)MLH1 c.301G>A p.Gly101Ser -Urether (51) -Colon (61) -Colon (66) -Kidney (67) -Urether (67) Clear cellMSSMLH1- MSH2+ MSH6+ 8 (M)MSH2 Exon 7 deletion -Colon (48) -Kidney (59) Papillary type 2MSSMLH1+ MSH2- MSH6- 9 (F)MLH1 c.2181_2182delCA p.His727fsx5 -Colon (29) -Colon (55) -Kidney (58) Clear cellMSSMLH1- MSH2+ MSH6+

PROPOSAL: EVALUATION OF CLINICAL AND MOLECULAR CHARACTERISTICS OF RCC ASSOCIATED WITH LYNCH SYNDROME 1.Age and sex 2.Histology 3.Detection (sympt. /screening/incidental) 4.MSI 5.IHC 6.Tumor DNA for other studies (i.e. VHL mutations, 3p loss, array-CGH) can be performed in Rome if requested